Your shopping cart is currently empty

Ac9-25 acetate is an annexin AI peptide and activates the neutrophil reduced nicotinamide adenine dinucleotide phosphate oxidase through FPR but not through FPRL1.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $78 | - | In Stock | |
| 5 mg | $175 | - | In Stock | |
| 10 mg | $260 | - | In Stock | |
| 25 mg | $415 | - | In Stock | |
| 50 mg | $559 | - | In Stock | |
| 100 mg | $749 | - | In Stock | |
| 200 mg | $1,000 | - | In Stock |
| Description | Ac9-25 acetate is an annexin AI peptide and activates the neutrophil reduced nicotinamide adenine dinucleotide phosphate oxidase through FPR but not through FPRL1. |
| In vitro | At a concentration of 20 μM, the N-terminal annexin I peptides Ac9-25 acetate markedly interfere with the transendothelial passage of neutrophils. Peptides derived from the N-terminal domains of other annexins do not elicit an inhibitory effect. Titration experiments show that a 50% inhibition of neutrophil transmigration is observed at ~5 μM annexin I peptide with Ac9-25 acetate[1]. |
| Synonyms | Ac9-25 acetate(284040-76-2 free base) |
| Molecular Weight | 2243.38 |
| Formula | C101H147N23O35 |
| Smiles | CC(O)=O.O=C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC4=CC=C(C=C4)O)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C |
| Relative Density. | no data available |
| Sequence | Ac-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys |
| Sequence Short | QAWFIENEEQEYVQTVK |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.